Primary Site >> Colorectal Cancer
Gene >> MUC16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers]. PMID: 2456040 |
Ref: Novel epitopes on the CA50-carrying antigen: chemical and immunochemical studies. PMID: 1712509 Ref: [Serum CA125 in patients with gastric cancer or colon cancer was transiently increased after curative resection: preliminary report]. PMID: 1770940 Ref: Evaluation of TATI and other markers in solid tumors. PMID: 1780686 |
Ref: Preoperative discrimination between ovarian carcinoma, non-ovarian gynecological malignancy and benign adnexal masses using serum levels of CA125 and the polymorphic epithelial mucin antigens CASA, OSA and MSA. PMID: 11576246 |
Ref: Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. PMID: 8980361 Ref: Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. PMID: 9252706 Ref: Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. PMID: 9329569 Ref: Immunophenotype of human HT29 colon cancer cell metastases in the lungs of scid mice: spontaneous versus artificial metastases. PMID: 9561026 |
Ref: Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. PMID: 9596273 Ref: Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. PMID: 9607566 Ref: Leukocyte alkaline phosphatase, CA15-3, CA125, and CEA in cancer patients. PMID: 9678617 Ref: OVX1 and CEA in patients with colon carcinoma, colon polyps and benign colon disorders. PMID: 10079388 |
Ref: Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. PMID: 10506443 Ref: Tumor marker determination after orthotopic heart transplantation. PMID: 10561106 |
Ref: Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis. PMID: 10884806 Ref: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. PMID: 11189683 |
Ref: High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. PMID: 12883737 Ref: A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer. PMID: 14612890 Ref: Tissue polypeptide specific antigen in the post therapeutic evaluation of patients with ovarian and colorectal cancer. PMID: 23105370 |
Ref: Mucins and mucin binding proteins in colorectal cancer. PMID: 15000151 Ref: Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers. PMID: 15362750 |
Ref: Diagnosis and management of simple ovarian cysts: an audit. PMID: 15727606 Ref: Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16). PMID: 15870874 Ref: [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer]. PMID: 15938925 Ref: The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray. PMID: 16100458 Ref: Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. PMID: 16336453 |
Ref: Screening for familial ovarian cancer--management and outcome of women with moderate to high risk of developing ovarian cancer. PMID: 16515573 Ref: Sister Mary Joseph's nodule as a presenting sign of internal malignancy. PMID: 16957443 |
Ref: Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall. PMID: 17335881 Ref: Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. PMID: 17991322 Ref: Invasive micropapillary carcinoma of the colon: an immunohistochemical study. PMID: 18085384 Ref: Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. PMID: 18088084 |
Ref: Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum. PMID: 18816257 Ref: National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. PMID: 19042984 |
Ref: Hereditary ovarian cancer. PMID: 18656380 |
Ref: Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1. PMID: 21076463 Ref: Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. PMID: 21875276 |
Ref: Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset. PMID: 22614534 Ref: Proteomic profiling of a mouse model for ovarian granulosa cell tumor identifies VCP as a highly sensitive serum tumor marker in several human cancers. PMID: 22870330 Ref: Endometrial and ovarian cancer in lynch syndrome. PMID: 23730224 Ref: [A case of primary seminal vesicle cancer detected by FDG-PET/CT]. PMID: 24261194 |
Ref: Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population. PMID: 23933921 Ref: Simultaneous detection of four biomarkers with one sensing surface based on redox probe tagging strategy. PMID: 24120163 |
Ref: Reversed polarity of the glandular epithelial cells in micropapillary carcinoma of the large intestine and the EMA/MUC1 immunostain. PMID: 25158820 Ref: A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor. PMID: 25551773 |
Ref: Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer. PMID: 24875250 Ref: Clinical Application of Serum Tumor Abnormal Protein (TAP) in Colorectal Cancer Patients. PMID: 25921156 Ref: A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers. PMID: 25987887 Ref: Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. PMID: 26035703 Ref: GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer. PMID: 26284141 Ref: Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: Results from a 12-year experience. PMID: 26344337 |
Ref: Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy. PMID: 26976996 Ref: Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options. PMID: 27074785 Ref: Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls. PMID: 27683121 Ref: Pseudo-Meigs' syndrome due to ovarian metastases from colon cancer: a case report and review of the literature. PMID: 27734419 Ref: Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women. PMID: 27893659 |
Ref: Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades. PMID: 27878480 Ref: Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. PMID: 28417967 |
Ref: Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. PMID: 29426902 Ref: Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers. PMID: 29636621 Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). PMID: 29786110 Ref: Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers? PMID: 29872358 Ref: The potential of exosomes derived from colorectal cancer as a biomarker. PMID: 30194933 Ref: Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas. PMID: 30236127 |